Habitu

Interactive Patient Communication Platform for Clinical Trials

Health Tech & Life Sciences
Acquired (Inactive) by RxE2 on Jan 2021 - closed due to acquisition
Acquired Herzliya Founded 2018
LinkedIn
Total raised
Last: Pre-Seed 2020-04
Stage
Acquired
Founded
2018
Headcount
1-10
HQ
Herzliya
Sector
Health Tech & Life Sciences

About

Habitu is developing an interactive communication platform to help inform, engage, track, and personalize the patient experience while driving interventions based on behavior predictions in decentralized environments such as home hospitalization and clinical trials. Habitu's platform is designed to provide a seamless, continuous flow of information between the patient, supporting care circle (e.g. family), and medical or clinical teams, both on-site and off, along with self-treatment recommendations. The platform manages the patient's commitment to treatment, predicts treatment dropout, provides alerts and actionable insights to the medical or clinical staff, and recommends a mix of automated and human interventions.

Funding history · 1 round · — total

2020-04
Pre-Seed Undisclosed

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcarePatient Engagement
Technologies
Platforms & InterfacesMobileArtificial Intelligence
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatientsProviders
Business model
B2B2C

Tags

chronic-patientsrecommendationsdigital-healthcaremobile-applicationsclinical-trialspatient-engagementfamilypatientspharma-companiesvideopersonalizationadherencemedicationartificial-intelligenceactionable-insights